Oral Biologics & Biosimilars Market Global Report 2020-30
- 7616
- Pages: 200
- April 2020
- Total Views:1458
- Region : Global
- The Business Research Company
- Market Research Report

Details
Table Of Content
Scope
1. Executive Summary
2. Oral Biologics & Biosimilars Market Market Characteristics
3. Oral Biologics & Biosimilars Market Market Size And Growth
3.1. Global Oral Biologics & Biosimilars Market Historic Market, 2015-2019, USD Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Oral Biologics & Biosimilars Market Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Oral Biologics & Biosimilars Market Market Segmentation
4.1. Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Lymphocyte Modulators
Interleukin Inhibitors
Tumor Necrosis Factor-Alpha Inhibitors
4.2. Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Asthma
Crohn'S Disease
Carcinoma
Arthritis
Diabetes
Multiple Myeloma
Enterocolitis
Multiple Sclerosis
Sarcoma
Psoriasis and Others
5. Oral Biologics & Biosimilars Market Market Regional And Country Analysis
5.1. Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
5.2. Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
6. Asia-Pacific Oral Biologics & Biosimilars Market Market
6.1. Asia-Pacific Oral Biologics & Biosimilars Market Market Overview
6.2. Asia-Pacific Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
7. China Oral Biologics & Biosimilars Market Market
7.1. China Oral Biologics & Biosimilars Market Market Overview
7.2. China Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion
8. India Oral Biologics & Biosimilars Market Market
8.1. India Oral Biologics & Biosimilars Market Market Overview
8.2. India Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
9. Japan Oral Biologics & Biosimilars Market Market
9.1. Japan Oral Biologics & Biosimilars Market Market Overview
9.2. Japan Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
10. Australia Oral Biologics & Biosimilars Market Market
10.1. Australia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
11. Indonesia Oral Biologics & Biosimilars Market Market
11.1. Indonesia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
12. South Korea Oral Biologics & Biosimilars Market Market
12.1. South Korea Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
13. Western Europe Oral Biologics & Biosimilars Market Market
13.1. Western Europe Oral Biologics & Biosimilars Market Market Overview
13.2. Western Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
14. UK Oral Biologics & Biosimilars Market Market
14.1. UK Oral Biologics & Biosimilars Market Market Overview
14.2. UK Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
15. Germany Oral Biologics & Biosimilars Market Market
15.1. Germany Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
16. France Oral Biologics & Biosimilars Market Market
16.3. France Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
17. Eastern Europe Oral Biologics & Biosimilars Market Market
17.1. Eastern Europe Oral Biologics & Biosimilars Market Market Overview
17.2. Eastern Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
18. Russia Oral Biologics & Biosimilars Market Market
18.1. Russia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
19. North America Oral Biologics & Biosimilars Market Market
19.1. North America Oral Biologics & Biosimilars Market Market Overview
19.2. North America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
20. USA Oral Biologics & Biosimilars Market Market
20.1. USA Oral Biologics & Biosimilars Market Market Overview
20.2. USA Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
21. South America Oral Biologics & Biosimilars Market Market
21.1. South America Oral Biologics & Biosimilars Market Market Overview
21.2. South America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
22. Brazil Oral Biologics & Biosimilars Market Market
22.1. Brazil Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
23. Middle East Oral Biologics & Biosimilars Market Market
23.1. Middle East Oral Biologics & Biosimilars Market Market Overview
23.2. Middle East Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
24. Africa Oral Biologics & Biosimilars Market Market
24.1. Africa Oral Biologics & Biosimilars Market Market Overview
24.2. Africa Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
25. Oral Biologics & Biosimilars Market Market Competitive Landscape And Company Profiles
25.1. Oral Biologics & Biosimilars Market Market Competitive Landscape
25.2. Oral Biologics & Biosimilars Market Market Company Profiles
25.2.1. Novartis
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Rani Therapeutics
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Eli Lilly and Co.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. AstraZeneca plc
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Novo Nordisk A/S
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market Market
27. Oral Biologics & Biosimilars Market Market Trends And Strategies
28. Oral Biologics & Biosimilars Market Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. The Business Research Company
29.5. Copyright And Disclaimer
List Of Figure
Figure 1: Global Historic Market Growth, 2015-2019, USD Billion
Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 3: Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 4: Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 5: Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 6: Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 7: Asia-Pacific, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 8: China, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 9: India, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 10: Japan, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 11: Australia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 12: Indonesia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 13: South Korea, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 14: Western Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 15: UK, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 16: Germany, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 17: France, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 18: Eastern Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 19: Russia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 20: North America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 21: USA, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 22: South America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 23: Brazil, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 24: Middle East, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 25: Africa, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 26: Novartis Financial Performance
Figure 27: Rani Therapeutics Financial Performance
Figure 28: Eli Lilly and Co. Financial Performance
Figure 29: AstraZeneca plc Financial Performance
Figure 30: Novo Nordisk A/S Financial Performance
List Of Table
Table 1: Global Historic Market Growth, 2015-2019, USD Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 3: Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 4: Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 5: Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 6: Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 7: Asia-Pacific, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 8: China, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 9: India, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 10: Japan, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 11: Australia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 12: Indonesia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 13: South Korea, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 14: Western Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 15: UK, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 16: Germany, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 17: France, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 18: Eastern Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 19: Russia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 20: North America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 21: USA, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 22: South America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 23: Brazil, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 24: Middle East, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 25: Africa, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 26: Novartis Financial Performance
Table 27: Rani Therapeutics Financial Performance
Table 28: Eli Lilly and Co. Financial Performance
Table 29: AstraZeneca plc Financial Performance
Table 30: Novo Nordisk A/S Financial Performance
Licence Rights
- Single User License (for access by one person)
- Site License (for access of one office location of a company)
- Corporate License (allow access by all staff of the company)
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors; 2) By Disease: Asthma; Crohn'S Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarcoma; Psoriasis and Others
Companies
Novartis; Rani Therapeutics; Eli Lilly and Co.; AstraZeneca plc; Novo Nordisk A/S; Biocon Limited; Oramed Pharmaceuticals; BiosanaPharma; Entera Bio Ltd.; Allergan plc; Emisphere Technologies; Enteris BioPharma; Chiasma; Allena Pharmaceuticals; Gelgen; Ganlee; 3sbio; Innovent; Retractable Technologies, Inc.; Changchun High Tech; Dong Bao; CP Guojian; GlaxoSmithKline Plc.; Concord Biotech; Aurobindo Pharma Ltd.; H. Lundbeck A/S; Sanofi-Aventis; Roche
Company Profile
Company Profile Title
Scope
1. Executive Summary
2. Oral Biologics & Biosimilars Market Market Characteristics
3. Oral Biologics & Biosimilars Market Market Size And Growth
3.1. Global Oral Biologics & Biosimilars Market Historic Market, 2015-2019, USD Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Oral Biologics & Biosimilars Market Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Oral Biologics & Biosimilars Market Market Segmentation
4.1. Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Lymphocyte Modulators
Interleukin Inhibitors
Tumor Necrosis Factor-Alpha Inhibitors
4.2. Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Asthma
Crohn'S Disease
Carcinoma
Arthritis
Diabetes
Multiple Myeloma
Enterocolitis
Multiple Sclerosis
Sarcoma
Psoriasis and Others
5. Oral Biologics & Biosimilars Market Market Regional And Country Analysis
5.1. Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
5.2. Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
6. Asia-Pacific Oral Biologics & Biosimilars Market Market
6.1. Asia-Pacific Oral Biologics & Biosimilars Market Market Overview
6.2. Asia-Pacific Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
7. China Oral Biologics & Biosimilars Market Market
7.1. China Oral Biologics & Biosimilars Market Market Overview
7.2. China Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion
8. India Oral Biologics & Biosimilars Market Market
8.1. India Oral Biologics & Biosimilars Market Market Overview
8.2. India Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
9. Japan Oral Biologics & Biosimilars Market Market
9.1. Japan Oral Biologics & Biosimilars Market Market Overview
9.2. Japan Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
10. Australia Oral Biologics & Biosimilars Market Market
10.1. Australia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
11. Indonesia Oral Biologics & Biosimilars Market Market
11.1. Indonesia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
12. South Korea Oral Biologics & Biosimilars Market Market
12.1. South Korea Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
13. Western Europe Oral Biologics & Biosimilars Market Market
13.1. Western Europe Oral Biologics & Biosimilars Market Market Overview
13.2. Western Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
14. UK Oral Biologics & Biosimilars Market Market
14.1. UK Oral Biologics & Biosimilars Market Market Overview
14.2. UK Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
15. Germany Oral Biologics & Biosimilars Market Market
15.1. Germany Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
16. France Oral Biologics & Biosimilars Market Market
16.3. France Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
17. Eastern Europe Oral Biologics & Biosimilars Market Market
17.1. Eastern Europe Oral Biologics & Biosimilars Market Market Overview
17.2. Eastern Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
18. Russia Oral Biologics & Biosimilars Market Market
18.1. Russia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
19. North America Oral Biologics & Biosimilars Market Market
19.1. North America Oral Biologics & Biosimilars Market Market Overview
19.2. North America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
20. USA Oral Biologics & Biosimilars Market Market
20.1. USA Oral Biologics & Biosimilars Market Market Overview
20.2. USA Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
21. South America Oral Biologics & Biosimilars Market Market
21.1. South America Oral Biologics & Biosimilars Market Market Overview
21.2. South America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
22. Brazil Oral Biologics & Biosimilars Market Market
22.1. Brazil Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
23. Middle East Oral Biologics & Biosimilars Market Market
23.1. Middle East Oral Biologics & Biosimilars Market Market Overview
23.2. Middle East Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
24. Africa Oral Biologics & Biosimilars Market Market
24.1. Africa Oral Biologics & Biosimilars Market Market Overview
24.2. Africa Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
25. Oral Biologics & Biosimilars Market Market Competitive Landscape And Company Profiles
25.1. Oral Biologics & Biosimilars Market Market Competitive Landscape
25.2. Oral Biologics & Biosimilars Market Market Company Profiles
25.2.1. Novartis
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Rani Therapeutics
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Eli Lilly and Co.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. AstraZeneca plc
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Novo Nordisk A/S
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market Market
27. Oral Biologics & Biosimilars Market Market Trends And Strategies
28. Oral Biologics & Biosimilars Market Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. The Business Research Company
29.5. Copyright And Disclaimer
List Of Figure
Figure 1: Global Historic Market Growth, 2015-2019, USD Billion
Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 3: Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 4: Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 5: Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 6: Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 7: Asia-Pacific, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 8: China, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 9: India, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 10: Japan, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 11: Australia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 12: Indonesia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 13: South Korea, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 14: Western Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 15: UK, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 16: Germany, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 17: France, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 18: Eastern Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 19: Russia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 20: North America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 21: USA, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 22: South America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 23: Brazil, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 24: Middle East, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 25: Africa, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 26: Novartis Financial Performance
Figure 27: Rani Therapeutics Financial Performance
Figure 28: Eli Lilly and Co. Financial Performance
Figure 29: AstraZeneca plc Financial Performance
Figure 30: Novo Nordisk A/S Financial Performance
List Of Table
Table 1: Global Historic Market Growth, 2015-2019, USD Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 3: Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 4: Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 5: Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 6: Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 7: Asia-Pacific, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 8: China, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 9: India, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 10: Japan, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 11: Australia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 12: Indonesia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 13: South Korea, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 14: Western Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 15: UK, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 16: Germany, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 17: France, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 18: Eastern Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 19: Russia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 20: North America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 21: USA, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 22: South America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 23: Brazil, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 24: Middle East, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 25: Africa, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 26: Novartis Financial Performance
Table 27: Rani Therapeutics Financial Performance
Table 28: Eli Lilly and Co. Financial Performance
Table 29: AstraZeneca plc Financial Performance
Table 30: Novo Nordisk A/S Financial Performance
- Single User License (for access by one person)
- Site License (for access of one office location of a company)
- Corporate License (allow access by all staff of the company)
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors; 2) By Disease: Asthma; Crohn'S Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarcoma; Psoriasis and Others
Companies
Novartis; Rani Therapeutics; Eli Lilly and Co.; AstraZeneca plc; Novo Nordisk A/S; Biocon Limited; Oramed Pharmaceuticals; BiosanaPharma; Entera Bio Ltd.; Allergan plc; Emisphere Technologies; Enteris BioPharma; Chiasma; Allena Pharmaceuticals; Gelgen; Ganlee; 3sbio; Innovent; Retractable Technologies, Inc.; Changchun High Tech; Dong Bao; CP Guojian; GlaxoSmithKline Plc.; Concord Biotech; Aurobindo Pharma Ltd.; H. Lundbeck A/S; Sanofi-Aventis; Roche